Resources

News and views on our work

• New recruitment mechanisms for cancer-associated fibroblasts in lung adenocarcinoma, 2023 Read →
• Collagen as a novel diagnostic and prognostic biomarker independent of TNM in lung cancer, 2023 Read →
• TIMP-1 as a new therapeutic target in lung adenocarcinoma, 2022 Read →
• How smoking impact on TGF-b signaling in fibroblasts mediates resistance to multi-tyrosine kinase inhibitor Nintedanib in Lung Cancer (collaboration with Boehringer-Ingelheim, Austria), 2019 Read →
• How fibroblasts modulate response to multi-tyrosine kinase inhibitor Nintedanib in Lung Cancer (collaboration with Boehringer-Ingelheim, Spain), 2015 Read →
• Crowdfunding campaing: “New approaches in the fight against lung cancer”, 2014 Read →
• Cover of the 12th issue of the journal of the Royal Society of Chemistry iBiology displays an image from our iBiology 2011 paper Read →
• Nomination of our EMBO J 2008 by the Faculty of 1000 Biology Read →

Outreach activities

• Online seminar at IBEC 2021
• TV interview on the international Lung Cancer day, 2022
• Interview on Animal Experimentation
• Contribution on a video about creativity in different disciplines

Teaching

We are actively involved in the following academic programs:

• Degree in Medicine, UB
• Degree in Molecular Biotechnology, UB
• Degree in Biomedical Engineering, UB
• Master in Biomedicine, UB

Funding sources (competitive calls)

• Agencia Estatal de Investigación AEI, Spain
• Instituto de Salud Carlos III ISCIII, Spain
• Asociación Española Contra el Cáncer AECC, Spain
• FET-OPEN, Horizon 2020, European Union
• ERA-NET Transcan-3, European Union
• Sociedad Española de Neumología y Cirugía Torácica SEPAR, Spain

Collaborations

Current and past collaborations with pharma and bioengineering companies

• Boheringer-Ingelheim Inc., Austria (*, +)
• Basilea Pharmaceutica, Switzerland (*, +)
• Artidis, Switzerland (*)
• Peptomyc, Spain (+)
• Alentis Therapeutics, Switzerland (*, +)
• Nordic Biosciences, Denmark (+)
• NextCure, US (+)

(* funded projects) (+ drugs or reagents provided)

Ongoing long-term collaborations (in alphabetic order)

• Oriol Casanovas, ICO-IDIBELL, Barcelona (Spain)
• Cristina Fillat, IDIBPAS, Barcelona (Spain)
• Luis Montuenga, CIMA, Pamplona (Spain)
• Josep Ramírez, Hospital Clínic, Barcelona (Spain)
• Noemi Reguart, IDIBAPS, Barcelona (Spain)
• Luca Roz, Istituto Nazionale dei Tumori, Milano (Italy)
• Derek Radisky, Mayo Clinic, Jacksonville FL (US)
• Xavier Trepat, IBEC, Barcelona (Spain)
• Josep Samitier, IBEC, Barcelona (Spain)

Clinical & Biomedical Institutions

• Functional Unit of Thoracic Tumors, Hospital Clínic, Barcelona (Spain)
• Institute for Bioengineering of Catalonia (IBEC), Barcelona (Spain)
• CIBER ES, Spain

Openings for Master students, Grad students and Postdocs

Our group is continuously open to students at the level of Master, Graduate (PhD) and Postdoctoral level. Please contact us to inquire about currently available positions and projects.

Support lung cancer research

Our research group accepts volunteer donations to support our lung cancer research. For this purpose, please contact the principal investigator of this group (Jordi Alcaraz) by email (jalcaraz@ub.edu) or telephone (+3493 403 1148). Likewise, should you have any doubt or different request on our research, please contact us!

You can help us by making a donation or spreading the word of our research.

Many thanks!